| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A pilot study for evaluating the feasibility of using alpha-defensin to support the diagnosis of ventriculitis
|
Doub, James B.
|
|
|
132 |
C |
p. 80-83
|
artikel
|
| 2 |
Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave – a nationwide study in Japan
|
Tanaka, Hiromu
|
|
|
132 |
C |
p. 84-88
|
artikel
|
| 3 |
Comparison of the clinical features of HIV-positive and HIV-negative hosts infected with Talaromyces marneffei: A multicenter, retrospective study
|
Qiu, Ye
|
|
|
132 |
C |
p. 93-98
|
artikel
|
| 4 |
Development of a case fatality prognostic score for HIV-associated histoplasmosis
|
Françoise, Ugo
|
|
|
132 |
C |
p. 26-33
|
artikel
|
| 5 |
Discovery of a novel sub-lineage of multi-drug resistant Shigella flexneri in Southern California
|
Kamau, Edwin
|
|
|
132 |
C |
p. 1-3
|
artikel
|
| 6 |
Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries
|
Yin, Sha
|
|
|
132 |
C |
p. 9-16
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
132 |
C |
p. i
|
artikel
|
| 8 |
Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
|
Diriba, Getu
|
|
|
132 |
C |
p. 50-63
|
artikel
|
| 9 |
Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon
|
Niba, Peter Thelma Ngwa
|
|
|
132 |
C |
p. 108-117
|
artikel
|
| 10 |
Global epidemiology and burden of tetanus from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
|
Li, Jun
|
|
|
132 |
C |
p. 118-126
|
artikel
|
| 11 |
High mortality risk of type III monomicrobial gram-negative necrotizing fasciitis: The role of extraintestinal pathogenic Escherichia coli (ExPEC) and Klebsiella pneumoniae
|
Cheng, Nai-Chen
|
|
|
132 |
C |
p. 64-71
|
artikel
|
| 12 |
Immediate and contributory causes of death in patients hospitalized with COVID-19
|
Butt, Adeel A.
|
|
|
132 |
C |
p. 4-8
|
artikel
|
| 13 |
Occurrence, resistance patterns, and management of carbapenemase-producing bacteria in war-wounded refugees from Ukraine
|
Berger, Fabian K.
|
|
|
132 |
C |
p. 89-92
|
artikel
|
| 14 |
Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment
|
Lee, Victor Ho-Fun
|
|
|
132 |
C |
p. 40-49
|
artikel
|
| 15 |
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic
|
Cohen, Dani
|
|
|
132 |
C |
p. 72-79
|
artikel
|
| 16 |
Randomized control study of the use of faropenem for treating patients with pulmonary tuberculosis
|
Shangguan, Yanwan
|
|
|
132 |
C |
p. 99-107
|
artikel
|
| 17 |
Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5
|
Molina, Kyle C.
|
|
|
132 |
C |
p. 34-39
|
artikel
|
| 18 |
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya
|
Chemwor, Gladys C.
|
|
|
132 |
C |
p. 17-25
|
artikel
|
Tijdschrift beschrijving